Vardenafil 5 mg Oral Tablet RxNorm 349478
Testosterone levels were elevated in all doses, especially for higher doses of vardenafil. Vardenafil with doses of 10 mg once or 5 mg twice is an effective and valid option for long-standing type II diabetic patients with ED. Diabetes mellitus (DM) is a chronic condition characterized by systemic inflammation that results in gradual organ damage.
- Vardenafil 5 mg is not suitable for individuals taking certain heart medications.
- The medication may cause dizziness or lightheadedness in some users.
- Proper storage extends shelf life and maintains potency.
- Lifestyle factors like stress can impact treatment success.
- Avoid heavy meals before taking Vardenafil 5 mg to speed absorption.
- The medication does not work without sexual stimulation.
- Be aware of potential interactions with other prescribed drugs.
- Patients should avoid driving if feeling dizzy after taking it.
- Consult your doctor if you experience prolonged or painful erections.
- Vardenafil 5 mg has a rapid onset but variable duration.
- It is important to review medical history before starting therapy.
- Combination therapy with other ED treatments should only be under medical supervision.
Hyperglycemia, insulin resistance, and the generation of free fatty acids play a significant role in endothelial dysfunction and DM comorbidity. The progression of endothelial dysfunction occurs in a phased manner, initially characterized by a diminished presence of vasodilatory agents, notably nitric oxide (NO). This is followed by an escalated expression of vasoconstrictive indicators, including molecules related to endothelial adhesion. Subsequently, there is an enhanced expression of proinflammatory mediators, encompassing interleukin (IL) and cytokines [Citation1]. Diabetic patients have ED at an earlier age and with greater frequency than nondiabetic males, with prevalence rates ranging from 20% to 75%. Diabetes affects both neuronal and vascular pathways [Citation2]. The release of NO from the distal nerve terminals of the penile penis causes the formation of cyclic GMP (cGMP) and, as a consequence, smooth muscle relaxation.
- Vardenafil 5 mg has a success rate of approximately 70-80% in clinical studies.
- It is often prescribed as a first-line treatment for ED.
- The tablet should be taken approximately 60 minutes before sex.
- Patients should avoid alcohol to reduce adverse effects.
- Exercise and dietary modifications can improve treatment outcomes.
- Patients should avoid grapefruit juice which can alter drug levels.
- Notify your doctor if erections last longer than 4 hours.
- Side effects may diminish over time with continued use.
- Use caution when operating machinery or driving.
- The medication is effective for men with diabetes-related ED.
- It is not approved for use in women or children.
- Always prioritize a doctor’s guidance regarding dosage and safety.
The predominant phosphodiesterase in the corpus cavernosum, cGMP-specific type 5 phosphodiesterase (PDE5), typically metabolizes cGMP. PDE5 inhibition boosts cGMP’s relaxing impact on smooth muscle [Citation3].
Before taking this medicine
The predominant phosphodiesterase in the corpus cavernosum, cGMP-specific type 5 phosphodiesterase (PDE5), typically metabolizes cGMP. PDE5 inhibition boosts cGMP’s relaxing impact on smooth muscle [Citation3]. The catalytic site of PDE5 is ordinarily involved in the degradation of cGMP. Inhibitors of PDE5, such as sildenafil, enhance the natural increases in cGMP by preventing its decomposition at the active sitePDE5 phosphorylation increases the enzyme’s enzymatic activity as well as the allosteric (noncatalytic/GAF domains) sites’ affinity for cGMP. The association of cGMP with these allosteric sites further amplifies the enzyme’s activity.
Key Takeaways
Consequently, the phosphorylation of PDE5 coupled with the attachment of cGMP to the allosteric sites plays a critical role in the negative feedback regulation of the cGMP signaling pathway [Citation4]. (2016) carried out the first double-blind, placebo-controlled clinical trial designed to evaluate the effects of chronic treatment of vardenafil on endothelial health-related parameters and sexual hormones in patients affected by a chronic disease. They stated that chronically administered vardenafil is effective and improves endothelial parameters in T2DM patient. Chronic vardenafil therapy improves hypogonadism in diabetic, hypogonadal men [Citation5]. (2008) observed the efficacy and safety of vardenafil in the treatment of ED in aged men with DM. The catalytic site of PDE5 is ordinarily involved in the degradation of cGMP. Inhibitors of PDE5, such as sildenafil, enhance the natural increases in cGMP by preventing its decomposition at the active sitePDE5 phosphorylation increases the enzyme’s enzymatic activity as well as the allosteric (noncatalytic/GAF domains) sites’ affinity for cGMP.
- Vardenafil 5 mg is used to treat erectile dysfunction in men.
- It works by increasing blood flow to the penis.
- Vardenafil 5 mg usually starts working within 30-60 minutes.
- The typical dosage for Vardenafil 5 mg is once daily.
- It is available by prescription only.
- Vardenafil 5 mg may cause side effects like headache or flushing.
- It is more effective when taken on an empty stomach.
- Alcohol can increase the risk of side effects with Vardenafil.
- Do not take Vardenafil 5 mg with nitrates or certain medications.
- Store Vardenafil 5 mg in a cool, dry place away from children.
- Consult your doctor before starting Vardenafil 5 mg.
- Report any persistent or severe side effects to your doctor.
The association of cGMP with these allosteric sites further amplifies the enzyme’s activity. Consequently, the phosphorylation of PDE5 coupled with the attachment of cGMP to the allosteric sites plays a critical role in the negative feedback regulation of the cGMP signaling pathway [Citation4]. (2016) carried out the first double-blind, placebo-controlled clinical trial designed to evaluate the effects of chronic treatment of vardenafil on endothelial health-related parameters and sexual hormones in patients affected by a chronic disease. They stated that chronically administered vardenafil is effective and improves endothelial parameters in T2DM patient. Chronic vardenafil therapy improves hypogonadism in diabetic, hypogonadal men [Citation5]. (2008) observed the efficacy and safety of vardenafil in the treatment of ED in aged men with DM. They concluded that vardenafil can significantly improve erectile function and is well tolerated in the aged males with diabetic ED [Citation6]. Similarly, a multicenter, double-blind, placebo-controlled study conducted by Goldstein et al. [Citation3,Citation7] assessed the efficacy and safety of vardenafil in men with diabetes-related ED. The results demonstrated that vardenafil significantly improved blue tablets erectile function and was generally well tolerated, with common adverse events being mild to moderate, such as headaches and flushing. There is limited research assessing how improvements in erectile function and hormonal status translate into partner satisfaction.
| Product | Dosage | Quantity + Bonus | Price | |
|---|---|---|---|---|
| Viagra Generic | 150mg | 60 + 4 Pills | 111.25€ 105.95€ | |
| Viagra Generic | 100mg | 120 + 6 Pills | 149.50€ 142.38€ | |
| Viagra Generic | 150mg | 270 + 10 Pills | 326.61€ 311.06€ | |
| Cialis Generic | 40mg | 360 + 10 Pills | 477.87€ 455.11€ | |
| Levitra Generic | 20mg | 10 Pills | 31.49€ 29.99€ | |
| Levitra Generic | 60mg | 30 + 2 Pills | 109.43€ 104.22€ | |
| Cialis Generic | 20mg | 270 + 10 Pills | 335.21€ 319.25€ | |
| Levitra Professional | 20mg | 60 + 2 Pills | 223.11€ 212.49€ | |
| Cialis Generic | 40mg | 60 + 6 Pills | 130.98€ 124.74€ | |
| Kamagra Polo | 100mg | 120 + 6 Pills | 327.15€ 311.57€ | |
| Tadalista Super Active | 20mg | 30 + 6 Pills | 128.09€ 121.99€ | |
| Levitra Generic | 10mg | 360 + 10 Pills | 407.94€ 388.51€ | |
| Cialis Super Active | 20mg | 180 + 20 Pills | 521.59€ 496.75€ | |
| Kamagra Effervescent Tablets | 100 mg | 28 Pills | 90.83€ 86.50€ | |
| Kamagra | 100mg | 12 Pills | 55.64€ 52.99€ | |
| Cialis Generic | 10mg | 360 + 10 Pills | 388.49€ 369.99€ |
Most studies have used the International Index of Erectile Function (IIEF) as the primary outcome, with fewer investigations using tools like the Erectile Dysfunction Inventory of Treatment Satisfaction (EDITS) to assess the partner’s perspective. Thus, the aim of this study was to investigate the efficacy and safety of different doses of vardenafil in patients with long-standing type II DM on erectile dysfunction, testosterone level and partner satisfaction, the primary outcome is to assess the Efficacy of the treatment was measured by self-filled questionnaire International Index of Erectile Function (IIEF) (erectile function, orgasmic function, sexual desire, and intercourse satisfaction) and The Partner satisfaction was assessed by The Erectile Dysfunction Inventory of Treatment Satisfaction (EDITS) questionnaire.
Data analysis
They concluded that vardenafil can significantly improve erectile function and is well tolerated in the aged males with diabetic ED [Citation6]. Similarly, a multicenter, double-blind, placebo-controlled study conducted by Goldstein et al. [Citation3,Citation7] assessed the efficacy and safety of vardenafil in men with diabetes-related ED. The results demonstrated that vardenafil significantly improved blue tablets erectile function and was generally well tolerated, with common adverse events being mild to moderate, such as headaches and flushing. There is limited research assessing how improvements in erectile function and hormonal status translate into partner satisfaction.
Prevention & Wellness
Most studies have used the International Index of Erectile Function (IIEF) as the primary outcome, with fewer investigations using tools like the Erectile Dysfunction Inventory of Treatment Satisfaction (EDITS) to assess the partner’s perspective. Thus, the aim of this study was to investigate the efficacy and safety of different doses of vardenafil in patients with long-standing type II DM on erectile dysfunction, testosterone level and partner satisfaction, the primary outcome is to assess the Efficacy of the treatment was measured by self-filled questionnaire International Index of Erectile Function (IIEF) (erectile function, orgasmic function, sexual desire, and intercourse satisfaction) and The Partner satisfaction was assessed by The Erectile Dysfunction Inventory of Treatment Satisfaction (EDITS) questionnaire. While the secondary outcome was to assess Testosterone level before and after administration of vardenafil. One hundred and two patients with long-standing type II diabetes presented to OPD with symptoms of ED between October 2021 and October 2022. Participants were allocated randomly to be administered varying dosages of vardenafil: 5 mg once daily, 5 mg twice daily, 10 mg once daily, and 10 mg twice daily, subsequent to the exclusion of individuals presenting contraindications for vardenafil (PDE5i) treatment. While the secondary outcome was to assess Testosterone level before and after administration of vardenafil. One hundred and two patients with long-standing type II diabetes presented to OPD with symptoms of ED between October 2021 and October 2022. Participants were allocated randomly to be administered varying dosages of vardenafil: 5 mg once daily, 5 mg twice daily, 10 mg once daily, and 10 mg twice daily, subsequent to the exclusion of individuals presenting contraindications for vardenafil (PDE5i) treatment.
Advancing Effective Research Policy
Patients who had Severe hepatic and renal failure, Malignancy or Penile congenital anomaly were also excluded. The patient’s demographic data, physical examination, laboratory assessment to assess glucose, HbA1c, total cholesterol, HDL, LDL, triglycerides. FSH and LH levels will be determined using ELISA. Testosterone concentrations will be quantified utilizing liquid chromatography-mass spectrometry at intervals before, throughout, and following a 6-month period of the medication’s administration. The Efficacy of the treatment will be measured by self-filled questionnaire International Index of Erectile Function (IIEF) [Citation8].
Pulmonary Arterial Hypertension (Orphan)
IIEF: is a validated, multidimensional, self-administrated questionnaire. Each of the 15 questions, which look at the four primary areas of male sexual function – erectile function, orgasmic function, sexual desire, and intercourse satisfaction – gets a score between 0 and 5. The International Index of Erectile Function-15 (IIEF-15) in Arabic was utilized for the Egyptian population (). The Erectile Dysfunction Inventory of Treatment Satisfaction (EDITS) questionnaire will be utilized for measuring partner satisfaction [Citation9]. EDITS is comprised of 11 queries, each evaluated using a scale ranging from 0 to 4 points, where a more elevated score signifies enhanced satisfaction levels. Patients who had Severe hepatic and renal failure, Malignancy or Penile congenital anomaly were also excluded. The patient’s demographic data, physical examination, laboratory assessment to assess glucose, HbA1c, total cholesterol, HDL, LDL, triglycerides. FSH and LH levels will be determined using ELISA. Testosterone concentrations will be quantified utilizing liquid chromatography-mass spectrometry at intervals before, throughout, and following a 6-month period of the medication’s administration. The Efficacy of the treatment will be measured by self-filled questionnaire International Index of Erectile Function (IIEF) [Citation8]. IIEF: is a validated, multidimensional, self-administrated questionnaire. Each of the 15 questions, which look at the four primary areas of male sexual function – erectile function, orgasmic function, sexual desire, and intercourse satisfaction – gets a score between 0 and 5.
Pregnancy & Lactation
Erectile dysfunction (ED), a prevalent sexual malady among adult males, exerts considerable impact across biological, psychological, and social dimensions, markedly affecting the quality of life (QOL) for affected men as well as their sexual partners or spouses [Citation10] Indeed, the widespread occurrence of ED has escalated into a matter of international health concern [Citation11]. The incidence rates of ED among men are distributed as follows: between 14.3% and 70% for those aged ≥60 years, 6.7% to 48% for individuals aged ≥70 years, and 38% for men who are ≥80 years old [Citation12]. The International Index of Erectile Function-15 (IIEF-15) in Arabic was utilized for the Egyptian population (). The Erectile Dysfunction Inventory of Treatment Satisfaction (EDITS) questionnaire will be utilized for measuring partner satisfaction [Citation9]. EDITS is comprised of 11 queries, each evaluated using a scale ranging from 0 to 4 points, where a more elevated score signifies enhanced satisfaction levels. An EDITS Index shall be derived through the multiplication of the average score across all 11 items by 25, thereby generating a spectrum of potential outcomes that spans from 0 (denoting the minimal level of satisfaction) to 100 (indicating the maximal level of satisfaction).
| Storage Condition | Recommended Temperature | Light & Moisture Protection | Shelf Life |
|---|---|---|---|
| In a cool, dry place | 15-30°C (59-86°F) | Keep in tightly sealed container | 2-3 years from manufacture date |
| Keep out of reach of children | Yes | Yes | |
| Avoid exposure to humidity | No | Store away from sunlight |
Additionally, the EDITS Partner buy tadalista 60 questionnaire is formulated to include five distinct items, each subject to scoring on a scale that extends from 0 to 4 points. Sample Size: This investigation is founded on research conducted by Bromby et al., 2018, wherein Epi Info STATCALC facilitated the computation of the requisite sample size, premised on specific presumptions: a 95% bi-directional confidence interval, coupled with a statistical power of 80%, and an anticipated error margin of 5% leading to an odds ratio of 1.115. The conclusive maximal sample size derived from the Epi Info output stood at 94. Consequently, to accommodate potential attrition throughout the follow-up phase, the sample size was augmented to a total of 100 subjects. The investigational endeavors secured the imprimatur of ethical review bodies, specifically underscored by Approval Number: FWA 00015574, FMBSUREC/009022020/Mohammed (Faculty of Medicine Beni Suef University Research Ethical Committee/009022020/Mohamed). Elicitation of participants’ consent, premised upon comprehensive informed consent protocols, anteceded their enrollment in the study. Stringent observance of established guidelines and regulatory frameworks punctuated the execution of all procedural facets Data entry and analysis will be made by using SPSS software (SPSS 20.0 Version). The collected data will be entered, coded, cleaned and analyzed using SPSS program (Version 25) for windows. Descriptive statistics will be calculated to include means, standard deviations for normally distributed quantitative variables and medians, ranges for quantitative variables which are not normally distributed. Frequencies will be calculated for qualitative variables (numbers and percentages).
Related/similar drugs
An EDITS Index shall be derived through the multiplication of the average score across all 11 items by 25, thereby generating a spectrum of potential outcomes that spans from 0 (denoting the minimal level of satisfaction) to 100 (indicating the maximal level of satisfaction). Additionally, the EDITS Partner buy tadalista 60 questionnaire is formulated to include five distinct items, each subject to scoring on a scale that extends from 0 to 4 points. Sample Size: This investigation is founded on research conducted by Bromby et al., 2018, wherein Epi Info STATCALC facilitated the computation of the requisite sample size, premised on specific presumptions: a 95% bi-directional confidence interval, coupled with a statistical power of 80%, and an anticipated error margin of 5% leading to an odds ratio of 1.115. The conclusive maximal sample size derived from the Epi Info output stood at 94. Consequently, to accommodate potential attrition throughout the follow-up phase, the sample size was augmented to a total of 100 subjects.
Health News
The investigational endeavors secured the imprimatur of ethical review bodies, specifically underscored by Approval Number: FWA 00015574, FMBSUREC/009022020/Mohammed (Faculty of Medicine Beni Suef University Research Ethical Committee/009022020/Mohamed). Elicitation of participants’ consent, premised upon comprehensive informed consent protocols, anteceded their enrollment in the study. Stringent observance of established guidelines and regulatory frameworks punctuated the execution of all procedural facets Data entry and analysis will be made by using SPSS software (SPSS 20.0 Version). The collected data will be entered, coded, cleaned and analyzed using SPSS program (Version 25) for windows. Descriptive statistics will be calculated to include means, standard deviations for normally distributed quantitative variables and medians, ranges for quantitative variables which are not normally distributed. Suitable statistical tests will be employed to evaluate the disparities among the groups. A p value falling below 0.05 will be interpreted as indicative of statistical significance.
Ethical approval
Frequencies will be calculated for qualitative variables (numbers and percentages). Suitable statistical tests will be employed to evaluate the disparities among the groups. A p value falling below 0.05 will be interpreted as indicative of statistical significance. The mean age of studied patients was 55.45 years (SD = 8.142), ranging from (40 to 65 years), HbA1c mean was 8.8% ± 1.5 which indicates uncontrolled diabetes and thus major effect on erectile dysfunction. Regarding the descriptive analysis of laboratory data of the studied patients, the mean hemoglobin was 13.1 mg/dl, ± 1.7, the mean WBCs was 5.2 ± 1.9, there was no statistically significant difference between groups regarding laboratory analysis, .
What should I do if I miss a dose of vardenafil?
In relation to the EDITS, IIEF scores, and testosterone levels, an enhancement post-vardenafil administration was noted in all groups. However, a statistically significant difference was observed in the EDITS scores specifically among the groups administered 5 mg twice daily and 10 mg once daily, p = 0.02, , . While a significant difference was noted in age distribution among the four vardenafil dosage groups (p = 0.041), the intergroup comparisons did not reveal statistically significant differences after Bonferroni correction. Testosterone levels were elevated with increased doses of vardenafil, applying ROC curve analysis showed that testosterone cut-off value was 1328.9, AUC = 0.446, . Considering the relation between HbA1c and baseline Testosterone, there was no significant correlation between both variables, using regression plot curve, p-value 0.5, . The mean age of studied patients was 55.45 years (SD = 8.142), ranging from (40 to 65 years), HbA1c mean was 8.8% ± 1.5 which indicates uncontrolled diabetes and thus major effect on erectile dysfunction. Regarding the descriptive analysis of laboratory data of the studied patients, the mean hemoglobin was 13.1 mg/dl, ± 1.7, the mean WBCs was 5.2 ± 1.9, there was no statistically significant difference between groups regarding laboratory analysis, . In relation to the EDITS, IIEF scores, and testosterone levels, an enhancement post-vardenafil administration was noted in all groups. However, a statistically significant difference was observed in the EDITS scores specifically among the groups administered 5 mg twice daily and 10 mg once daily, p = 0.02, , . While a significant difference was noted in age distribution among the four vardenafil dosage groups (p = 0.041), the intergroup comparisons did not reveal statistically significant differences after Bonferroni correction. Testosterone levels were elevated with increased doses of vardenafil, applying ROC curve analysis showed that testosterone cut-off value was 1328.9, AUC = 0.446, . Considering the relation between HbA1c and baseline Testosterone, there was no significant correlation between both variables, using regression plot curve, p-value 0.5, .
How RedBox Rx can help
Testosterone levels were elevated in all doses, especially for higher doses of vardenafil. Vardenafil with doses of 10 mg once or 5 mg twice is an effective and valid option for long-standing type II diabetic patients with ED. Diabetes mellitus (DM) is a chronic condition characterized by systemic inflammation that results in gradual organ damage. Hyperglycemia, insulin resistance, and the generation of free fatty acids play a significant role in endothelial dysfunction and DM comorbidity. The progression of endothelial dysfunction occurs in a phased manner, initially characterized by a diminished presence of vasodilatory agents, notably nitric oxide (NO).
Other Medical Problems
This is followed by an escalated expression of vasoconstrictive indicators, including molecules related to endothelial adhesion. Subsequently, there is an enhanced expression of proinflammatory mediators, encompassing interleukin (IL) and cytokines [Citation1]. Diabetic patients have ED at an earlier age and with greater frequency than nondiabetic males, with prevalence rates ranging from 20% to 75%. Diabetes affects both neuronal and vascular pathways [Citation2]. The release of NO from the distal nerve terminals of the penile penis causes the formation of cyclic GMP (cGMP) and, as a consequence, smooth muscle relaxation. Erectile dysfunction (ED), a prevalent sexual malady among adult males, exerts considerable impact across biological, psychological, and social dimensions, markedly affecting the quality of life (QOL) for affected men as well as their sexual partners or spouses [Citation10] Indeed, the widespread occurrence of ED has escalated into a matter of international health concern [Citation11]. The incidence rates of ED among men are distributed as follows: between 14.3% and 70% for those aged ≥60 years, 6.7% to 48% for individuals aged ≥70 years, and 38% for men who are ≥80 years old [Citation12].